Inaugural Call for Papers — Volume 1 (2026)
The International Journal of Pharmacology, Pharmacotherapeutics and Therapy invites submissions for its inaugural volume. The Article Processing Charge (APC) is ₹1,000 per accepted article following successful peer review.
An Academic Forum for Advances in Pharmacology, Clinical Pharmacy, and Patient Therapeutics
The International Journal of Pharmacology, Pharmacotherapeutics and Therapy is an independent, peer-reviewed, open-access journal established to publish high-rigor scientific investigations, clinical trials, systematic reviews, and observational studies. Our editorial focus connects mechanistic pharmacological discovery with evidence-based pharmacotherapeutic decision-making, hospital pharmacy practice, medication safety, and clinical patient outcomes.
Inaugural Volume Information
- Current Volume
- Volume 1 (2026)
- Publication Schedule
- Continuous Online
- Evaluation Model
- Double-Blind Peer Review
- Article Processing Charge
- ₹1,000 / Accepted Article
- Submissions
- Open for Review
Featured Research & Editorial
Inaugural Featured Investigation (Selection in Progress)
This space is reserved for a featured original investigation, systematic meta-analysis, or invited clinical review selected by the editors from manuscripts currently under double-blind peer review for Volume 1. In keeping with publishing integrity, no placeholder or artificial research findings are listed.
Author Call:
Researchers with high-impact clinical pharmacology findings, therapeutic drug monitoring evaluations, or hospital medication safety studies are encouraged to submit their work for consideration.
Current Issue
The inaugural issue is currently accepting submissions. All articles are published online continuously immediately upon completion of peer review, author corrections, and DOI registration.
The International Journal of Pharmacology, Pharmacotherapeutics and Therapy invites submissions for its inaugural volume. The Article Processing Charge (APC) is ₹1,000 per accepted article following successful peer review.
View announcement →Subject Disciplines & Research Scope
The journal welcomes original research articles, systematic reviews, and clinical communications across six foundational pharmaceutical and therapeutic domains:
Clinical Pharmacology
Human pharmacology, pharmacokinetics (PK), pharmacodynamics (PD), dose-ranging, bioequivalence, and therapeutic drug monitoring (TDM).
Pharmacotherapeutics
Clinical management of diseases, evidence-based medication protocols, comparative effectiveness studies, and targeted therapeutics.
Clinical Pharmacy
Hospital pharmacy practice, clinical pharmacist interventions, ward round observations, medication reconciliation, and pharmaceutical care.
Pharmacovigilance
Adverse drug reaction (ADR) detection, post-marketing safety surveillance, risk mitigation plans, and regulatory drug safety.
Medication Safety
Prevention of prescribing and dispensing errors, drug-drug and drug-food interaction screening, and patient safety in vulnerable populations.
Therapeutics
Comprehensive medical therapy, translational medicine, supportive care in oncology and chronic disease, and personalized therapeutic regimens.
Latest Articles
Volume 1, Issue 1 Submissions Under Review
The journal is currently reviewing manuscripts submitted for the inaugural issue. To ensure academic rigor and transparent scholarly records, no fabricated articles, provisional citations, or simulated statistics are published. Accepted papers will appear in this index continuously as peer review is completed.
[DEMO CONTENT] Population Pharmacokinetic Modeling and Therapeutic Drug Monitoring Optimization: A Demonstration Article Template
[Demo Author A, Demo Author B, Demo Author C] — [Department of Clinical Pharmacy & Therapeutics Placeholder]
[Abstract Placeholder]: This demonstrative card illustrates the typographic hierarchy, digital identifiers, author bylines, and open-access licensing terms that will accompany every published paper once the peer-review cycle is complete.
Author Resources & Publishing Policies
Comprehensive guidelines and editorial standards to assist authors, reviewers, and institutions in preparing manuscripts for publication:
Author Guidelines
IMRAD organization, structured abstracts (250 words), Vancouver reference style, and mandatory ethics declarations.
Peer Review Policy
Rigorous double-blind peer review involving a minimum of two independent external expert reviewers.
Publication Ethics
Compliance with COPE Core Practices, ICMJE authorship criteria, anti-plagiarism screening, and retraction protocols.
Publication Fees & APC
Article Processing Charge (APC) of ₹1,000 per accepted article. No submission fees; fee applies solely following peer-review acceptance.
Editorial Transparency & Academic Governance
Our commitment to clear scholarly procedures, conflict-of-interest declarations, and peer-review rigor:
Editorial Board Structure
The international editorial council and peer-review college are currently in the formal process of academic constitution. Nominations with terminal degrees (MD, PharmD, PhD) are welcome.
View Board Constitution →Double-Blind Peer Review
Both author and reviewer identities are concealed throughout evaluation to eliminate bias associated with prominence, country, or institutional origin.
Read Peer Review Workflow →Open Access & Copyright
Articles are published under Creative Commons Attribution 4.0 licenses (CC BY), allowing immediate global sharing while preserving full author copyright.
Review Open Access Terms →Research Ethics & Declarations
All clinical trials require formal Institutional Review Board (IRB) approval, participant consent in compliance with the Declaration of Helsinki, and protocol registration.
Ethics Standards →Corrections & Retractions
The journal strictly follows COPE Retraction Guidelines. Errata, expressions of concern, and retractions will be published promptly and bidirectionally linked.
Retraction Policy →Conflict of Interest Disclosures
Authors, reviewers, and editors must declare all financial and personal relationships that could influence the impartiality of the manuscript or decision.
Declaration Rules →